Table 2.
Patients with Scheuermann's disease |
Health 2000 controls |
Patients with Scheuermann's disease |
p-valuesb | |
---|---|---|---|---|
n = 22 |
n = 26 |
|||
mean (SD) | mean (SD) | mean difference (95 %CI)a | ||
General health c | 6.6 (2.4) | 8.0 (1.7) | −1.02 (−2.50-0.96) | 0.069 |
The quality of life c | 6.9 (2.5) | 7.9 (1.7) | −0.92 (−2.22-0.39) | 0.163 |
Five-repetition sit-to-stand test (seconds) | 15.1 (6.6) | 11.7 (2.8) | 3.37 (−0.11-6.85) | 0.057 |
Walking time in 6.1 m (seconds) | 4.0 (1.8) | 3.6 (1.0) | 0.53 (−0.43-1.50) | 0.269 |
Number of steps during 6.1 m | 8.4 (2.3) | 7.4 (1.1) | 1.05 (−0.12-2.22) | 0.076 |
Walking speed (m/s) | 1.7 (0.5) | 1.8 (0.4) | −0.10 (−0.40-0.10) | 0.485 |
% |
% |
OR (95% CI)d |
||
Constant back pain, (%) | 41 | 8 | 9.41 (1.56–56.97) | 0.015 |
Disability because of back pain during last 5 years, (%) | 50 | 12 | 5.48 (1.19–25.23) | 0.029 |
Back pain during last 30 days, (%) | 68 | 4 | 45.00 (4.92–411.32) | 0.001 |
Sciatica, (%) | 50 | 46 | 1.21 (0.36–4.09) | 0.755 |
Constant sciatica, (%) | 14 | 4 | 4.76 (0.40–56.89) | 0.217 |
Neck pain during last 30 days, (%) | 59 | 8 | 27.26 (3.95–188.05) | 0.001 |
Shoulder pain during last 30 days, (%) | 55 | 8 | 14.13 (2.48–80.55) | 0.003 |
Difficulties carrying 5-kg load at least 100 m, (%) | 36 | 0 | ||
Difficulties in walking up one floor without resting, (%) | 27 | 4 | 9.82 (1.01–95.34) | 0.049 |
Other chronic diseases, (%) | 77 | 46 | 3.36 (0.89–12.63) | 0.073 |
ANCOVA, age-adjusted mean difference and its 95% CI confidence intervals [95% CI] for general health, quality of life and physical function in male patients with Scheuermann's disease (n = 22) compared to male controls (n = 26), adjusted for age.
p-values are distributed between patients and controls.
Self-reported outcomes measured by visual analogue scale (VAS), 0 to 10, where 0 is the worst and 10 is the best possible.
Odds Ratios [OR] and their 95% confidence intervals [95% CI] for back symptoms and activities of daily living in male patients with Scheuermann's disease (n = 22) compared to male controls (n = 26), adjusted for age.